Drugs / ETX-018810
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04778592 | Jan 2021 → May 2022 | radiculopathy | Eliem Therapeutics (UK) Ltd. | Completed | Missed primary |
| Phase 2 | NCT04688671 | Nov 2020 → Feb 2022 | diabetic polyneuropathy, neuropathy, painful | Eliem Therapeutics (UK) Ltd. | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ETX-018810 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04778592 ↗ |